Rosuvastatin Calcium Tablet
Product Images NDC 68788-8775

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 68788-8775). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rosuvastatin Calcium Tablets 10mg (Rosuvastatin Tablets 10mg 90s Bottle Label)

This text is a label for Rosuvastatin Calcium Tablets. Each tablet contains 10mg of Rosuvastatin calcium, a generic for Crestor. The tablets are film-coated and manufactured by Umedica Laboratories Pvt. Ltd. The label provides storage instructions, warns to keep out of reach of children, and mentions the round, pink appearance of the tablets. It also includes a caution about the transfer of the medication to anyone other than the prescribed patient.*

FDA Label Image

Figure_1_time_jupiter (Rosuvastatin Tablets Figure 1)

The text provides hazard ratio (HR) of 0.56 with 95% confidence interval of 0.46-0.69, indicating a significant difference (p<0.001). The cumulative incidence in percentage is not available due to the garbled text. The data also presents the number at risk over different time intervals for RSV and Placebo groups.*

FDA Label Image

Figure_2-major_jupiter (Rosuvastatin Tablets Figure 2)

This text provides data comparing the effects of Rosuvastatin 20mg versus placebo on various cardiovascular events in a study with a total of 8901 participants. The results show a significant reduction in the primary endpoint, major cardiovascular events, with a Hazard Ratio of 0.56. The text also includes data on specific outcomes such as cardiovascular death, nonfatal stroke, nonfatal myocardial infarction (MI), and arterial revascularization. The event rates per 1000 patient-years are provided for each endpoint.*

FDA Label Image

Figure_3_percent_dyslipidemia (Rosuvastatin Tablets Figure 3)

FDA Label Image

Logo (Rosuvastatin Tablets Logo)

FDA Label Image

Logo1 (Rosuvastatin Tablets Logo2)

FDA Label Image

Structural_formula (Rosuvastatin Tablets Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.